LC
FBIO icon

Lindbrook Capital’s Fortress Biotech FBIO Stock Holding History

Lindbrook Capital’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$8 – 2734
2023
Q3 		$8 Hold
2
– – ﹤0.01% 2681
2023
Q2 		$16 Hold
2
– – ﹤0.01% 2694
2023
Q1 		$24 Hold
2
– – ﹤0.01% 2758
2022
Q4 		$19 Hold
2
– – ﹤0.01% 2808
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2706
2022
Q2 		$0 Hold
2
– – ﹤0.01% 2566
2022
Q1 		$0 Hold
2
– – ﹤0.01% 2518
2021
Q4 		$0 Hold
2
– – ﹤0.01% 2116
2021
Q3 		$0 Hold
2
– – ﹤0.01% 1892
2021
Q2 		$0 Buy
+2
New +$121 ﹤0.01% 1936

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lindbrook Capital's FBIO Position: Q4 2023 in Review

Lindbrook Capital sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 2 shares — an estimated $8 sold.

Lindbrook Capital first reported a position in FBIO in Q2 2021 and held it in 10 quarters. The position peaked at $24 in Q1 2023. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • Lindbrook Capital reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • Lindbrook Capital sold 2 Fortress Biotech shares in Q4 2023, an estimated $8.
  • Lindbrook Capital first reported a position in Fortress Biotech in Q2 2021 and held it in 10 quarters.
  • Lindbrook Capital's Fortress Biotech position peaked at $24 in Q1 2023.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.